Eight people on the NIH and FDA panel for Covid oversaw the remdesavir trial got paid directly by Gilead. They changed the endpoint of the study from mortality to a fluffy metric of just recovery time on surviving patients.
Out of thousands of drug trials that I have seen, I have never seen anything like that, especially not with an instant FDA rubber stamp to follow.
Washington Post: Government researchers changed metric to measure coronavirus drug remdesivir during clinical trial https://www.msn.com/en-us/news/us/government-researchers-changed-metric-to-measure-coronavirus-drug-remdesivir-during-clinical-trial/ar-BB13ui2k
This is the panel that oversaw the Remdesivir study:
Leave a Reply